Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from South-East Asia and India

by Matthew Bonaparte, Bashir Dweik, Emmanuel Feroldi, Claude Meric, Alain Bouckenooghe, Stephen Hildreth, Branda Hu, Sutee Yoksan, Mark Boaz
Published 2018

Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5?6 years after completion of...

by Eujung Juliana Park, Sophia Archuleta, May-Lin Helen Oh, Lynette P Shek, Jing Jin, Matthew Bonaparte, Carina Fargo, Alain Bouckenooghe
Published 2020

Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-...

by Eujung Juliana Park, SOPHIA ARCHULETA, May-Lin Helen Oh, LYNETTE PEI-CHI SHEK, Hao Wang, Matthew Bonaparte, Carina Frago, Alain Bouckenooghe, Frederique Jantet-Blaudez, Sarah Begue, Sophie Gimenez-Fourage, Anke Pagnon
Published 2021

Impact of Dengue Vaccination on Serological Diagnosis: Insights from Phase III Dengue Vaccine Efficacy Trials

by Eric Plennevaux, Annick Moureau, José L. Arredondo-García, Luis Villar, Punnee Pitisuttithum, Ngoc H. Tran, Matthew Bonaparte, Danaya Chansinghakul, Diana L. Coronel, Maïna L'Azou, R. Leon Ochiai, Myew Ling Toh, Fernando Noriega, Alain Bouckenooghe
Published 2019